Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations.
Hyperlipidemia is a major modifiable risk factor for the primary and secondary prevention of cardiovascular diseases in the elderly population. Although statin therapy remains the mainstay of treatment for hyperlipidemia in the elderly, other therapies, including exercise training, plant stanols and sterols, soluble fiber, and drug combinations (especially ezetimibe, niacin, and/or fibrates alone or combined with statins) are also effective and important lipid therapies for the elderly population.
Lavie
Carl J
CJ
Department of Cardiovascular Diseases and Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. clavie@ochsner.org
D000368:Aged; D000369:Aged, 80 and over; D001384:Azetidines / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D015444:Exercise; D000069438:Ezetimibe; D015248:Gemfibrozil / Q000008:administration & dosage; D006299:Health Services for the Aged; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006949:Hyperlipidemias / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D009525:Niacin / Q000008:administration & dosage; D014481:United States
D001384:Azetidines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D000069438:Ezetimibe; D015248:Gemfibrozil